High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

Clinical trial NCT00936936 · COMPLETED

Trial details

NCT number: NCT00936936
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Testicular Cancer

Start date: 2009-06-02
Primary completion: 2024-01-11
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.